EXPRESS LICENSING TECHNOLOGIES

Subcategories

Results found (2)
No.CategoryTechnology NameBriefcaseLead Researcher
1731
Anti-CD48 agent blocks CD48 stimulatory pathway and inhibits the activity and expression of CD48 Categories Drugs, Allergic airway inflammations, Asthma Development Stage Laboratory and animal trials were performed Patent Status US Granted ...
More
Levi-Schaffer Francesca
2613
  Current development stage               TRL4 - POC in  relevant bacteria   Application There is a need to increase the susceptibility of bacteria to conventional antibiotics. The ability of bacteria to form biofilms is a significant ...
More
Steinberg Doron